- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT03726528
Optimized Characterization of Takotsubo Syndrome by Obtaining Pressure Volume Loops (OCTOPUS)
October 17, 2022 updated by: Prof. Dr. med. Ingo Eitel, University of Luebeck
Aim of this prospective study is to assess the pathophysiology of Takotsubo Syndrome by obtaining pressure volume loops with conductance catheters, which allows detailed conclusions regarding systolic and diastolic hemondynamics and subsequently regarding potential underlying mechanisms
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Study Type
Interventional
Enrollment (Actual)
25
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Schleswig-Holstein
-
Luebeck, Schleswig-Holstein, Germany, 23562
- Medical clinic II-UKSH
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years and older (ADULT, OLDER_ADULT)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Description
Inclusion Criteria:
- Confirmed Takotsubo syndrome according to current diagnostic criteria including complete normalization of left ventricular function during follow-up
- Sinus rhythm during invasive measurements
- Age ≥18 years
- Written informed consent
Exclusion Criteria:
- Cardiogenic shock
- Signs of myocarditis or myocardial infarction with spontaneous lysis of thrombus in cardiac magnetic resonance imaging
- Pregnancy
- Participation in another trial
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: DIAGNOSTIC
- Allocation: NA
- Interventional Model: SINGLE_GROUP
- Masking: NONE
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
EXPERIMENTAL: Experimental intervention
|
Patients with suspected Takotsubo syndrome (typical ballooning in left ventriculography without significant obstructive coronary artery disease that sufficiently explains the contraction abnormalities) will undergo continuous online measurements of left ventricular pressure and volume using conductance catheters.
Cardiac magnetic resonance (CMR) imaging will be performed in patients without contraindications for optimized morphological characterization and exclusion of important differential diagnoses.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Changes in contractility derived from pressure-volume measurements
Time Frame: Day 0
|
systolic/diastolic pressure-volume relationship (mmHg/ml)
|
Day 0
|
|
Changes in contractility derived from pressure-volume measurements
Time Frame: Day 0
|
peak-power index (mmHG/s)
|
Day 0
|
|
Changes in contractility derived from pressure-volume measurements
Time Frame: Day 0
|
peak filling rate (ml/s)
|
Day 0
|
|
Changes in contractility derived from pressure-volume measurements
Time Frame: Day 0
|
stroke work (mmHG x ml)
|
Day 0
|
|
Changes in contractility derived from pressure-volume measurements
Time Frame: Day 0
|
relaxation constant "Tau" (ms)
|
Day 0
|
|
Changes in contractility derived from pressure-volume measurements
Time Frame: Day 0
|
time to Emax (ms)
|
Day 0
|
|
Changes in contractility derived from pressure-volume measurements
Time Frame: Day 0
|
max/min rate of left ventricular pressure change (mmHg/s)
|
Day 0
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Energetic parameters derived from pressure-volume measurements
Time Frame: Day 0
|
stroke work, potential energy (mmHg x ml)
|
Day 0
|
|
Energetic parameters derived from pressure-volume measurements
Time Frame: Day 0
|
total pressure volume area (mmHg/ml)
|
Day 0
|
|
Afterload parameters derived from pressure-volume measurements
Time Frame: Day 0
|
arterial elastance (mmHg/ml)
|
Day 0
|
|
Afterload parameters derived from pressure-volume measurements
Time Frame: Day 0
|
ventricular arterial coupling (no dimension)
|
Day 0
|
|
Afterload parameters derived from pressure-volume measurements
Time Frame: Day 0
|
total arterial compliance (mmHg/ml)
|
Day 0
|
|
- Correlation of pressure-volume measurements with morphological and functional findings in CMR imaging
Time Frame: Day 3
|
(presence of myocardial edema or late gadolinium enhancement, native T1 time, myocardial strain assessed by CMR feature tracking)
|
Day 3
|
|
- Correlation of pressure-volume measurements with biomarker release
Time Frame: Day 0
|
(troponin, NT-proBNP)
|
Day 0
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (ACTUAL)
September 1, 2017
Primary Completion (ACTUAL)
October 7, 2022
Study Completion (ACTUAL)
October 7, 2022
Study Registration Dates
First Submitted
October 1, 2018
First Submitted That Met QC Criteria
October 29, 2018
First Posted (ACTUAL)
October 31, 2018
Study Record Updates
Last Update Posted (ACTUAL)
October 19, 2022
Last Update Submitted That Met QC Criteria
October 17, 2022
Last Verified
October 1, 2022
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 17-078
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
UNDECIDED
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Takotsubo Syndrome
-
NYU Langone HealthActive, not recruiting
-
Medical University of WarsawRecruiting
-
University of ZurichCompletedTakotsubo SyndromeSwitzerland
-
Vastra Gotaland RegionThe Sahlgrenska Academy at University of GothenburgRecruitingTakotsubo SyndromeNorway, Denmark, Sweden
-
University of MoliseActive, not recruitingTakotsubo Syndrome
-
Fondazione Policlinico Universitario Agostino Gemelli...Recruiting
-
University Hospital of FerraraTerminatedTakotsubo Cardiomyopathy | Takotsubo SyndromeItaly
-
Prof. Dr. med. Ingo EitelUniversity of FoggiaRecruiting
-
Weill Medical College of Cornell UniversityRecruiting
-
University Hospital HeidelbergGerman Centre of Cardiovascular Research (DZHK); Coordinating Centre for Clinical...Recruiting
Clinical Trials on Measurements of left ventricular pressure and volume
-
French Cardiology SocietyFrench Federation of CardiologyCompletedHeart Failure With Preserved Ejection Fraction (HFPEF) | Left Ventricular End Diastolic Pressure (LVEDP)France
-
Erasmus Medical CenterRecruitingExtracorporeal Membrane Oxygenation | Cardio/Pulm: Heart FailureNetherlands
-
Goethe UniversityDeutsches Zentrum für Herz-Kreislauf-Forschung (DZHK)CompletedHeart Failure With Normal Ejection FractionGermany
-
Assistance Publique Hopitaux De MarseilleCompleted
-
Shanghai 10th People's HospitalUnknown
-
RenJi HospitalNingbo Hangzhou Bay Hospital; Jiading Central HospitalRecruitingOverweight and ObesityChina
-
University Hospital, RouenRecruiting
-
St. Luke's-Roosevelt Hospital CenterMontefiore Medical CenterCompletedHeart Failure | Cardiac Resynchronization TherapyUnited States
-
Medical College of WisconsinCompletedEndothelial Dysfunction | Heart Failure With Reduced Ejection Fraction | LVADUnited States